Using a syngeneic BC mouse cancer cell line in conjunction with the SRC-3 Treg cKO mice, the authors demonstrated that tumor eradication can be achieved when SRC-3 KO takes place in Tregs following tamoxifen induction of Cre-recombinase. The gene discussed is NCOA3; the disease is neoplasm.